US Stock MarketDetailed Quotes

ALXO ALX Oncology

Watchlist
  • 6.610
  • -1.050-13.71%
Close Jul 18 16:00 ET
344.38MMarket Cap-1781P/E (TTM)

ALX Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ALX Oncology Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.71

+4.05%
Analyst Rating

Strong Buy

Jul 18, 2024

ALX Oncology Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

ALX Oncology Earnings Reports

  • ALX Oncology | 10-Q: Quarterly report

    May 9 17:08 ET

  • ALX Oncology | 10-K: Annual report

    Mar 7 22:16 ET

  • ALX Oncology: Q3 2023 Earnings Report

    Nov 13, 2023 16:08 ET

  • ALX Oncology | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 16:10 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 18, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg